A method of treating the mental state of subjects with significant neurological, functional and/or motor impairment from an ischemic stroke. The method comprises a step of intravenously dosing ischemic tolerant allogeneic mesenchymal bone marrow cells itMSCs to subjects with ischemic stroke.
METHOD OF TREATING MENTAL STATE IN PATIENTS AFTER ISCHEMIC BRAIN INJURY WITH ISCHEMIC TOLERANT ALLOGENEIC MESENCHYMAL BONE MARROW CELLS